Aquatic Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Aquatic Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-87,588	Closed	-$877K	–	1381
2025 Q3	$877K	Buy	87,588 +40,209	+85%	+$361K	0.02%	715
2025 Q2	$383K	Buy	47,379 +42,533	+878%	+$321K	0.01%	886
2025 Q1	$40.6K	Sell	4,846 -52,764	-92%	-$440K	﹤0.01%	1150
2024 Q4	$456K	Buy	+57,610	New	+$483K	0.01%	738
2024 Q3	–	Sell	-17,100	Closed	-$109K	–	1130
2024 Q2	$109K	Sell	17,100 -54,800	-76%	-$348K	﹤0.01%	875
2024 Q1	$436K	Buy	+71,900	New	+$405K	0.01%	578
2022 Q4	–	Sell	-3,300	Closed	-$7K	–	1330
2022 Q3	$7K	Buy	3,300 +1,800	+120%	+$5.04K	﹤0.01%	1071
2022 Q2	$5K	Buy	+1,500	New	+$5.43K	﹤0.01%	1038

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aquatic Capital Management's AMRX Position: Q4 2025 in Review

Aquatic Capital Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 87,588 shares — an estimated $877K sold.

Aquatic Capital Management first reported a position in AMRX in Q2 2022 and held it in 8 quarters. The position peaked at $877K in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

Aquatic Capital Management reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Aquatic Capital Management sold 87,588 Amneal Pharmaceuticals shares in Q4 2025, an estimated $877K.
Aquatic Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2022 and held it in 8 quarters.
Aquatic Capital Management's Amneal Pharmaceuticals position peaked at $877K in Q3 2025.
277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.